Skip to main content

Veru Inc.

VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000863894

In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Veru Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of VERU: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders11198−13
Shares23.3M22.7M−599.5K (−2.6%)
Value$137.3M$110.3M−$27.0M (−19.7%)

New holders (11)

Institutions that held Veru Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to VERU in Q1 2022
InstitutionSharesValue% of portfolio
Graham Capital Management, L.P.105,798$511.0K0.02%
Marshall Wace, LLP77,581$375.0K0.00%
Prudential Financial Inc71,690$346.0K0.00%
Walleye Capital LLC34,100$165.0K0.00%
Algert Global LLC12,848$62.0K0.00%
Amalgamated Financial Corp.9,744$47.0K0.00%
STRS Ohio4,400$21.0K0.00%
IFP Advisors, Inc300$3.00K0.00%
Money Concepts Capital Corp350$2.00K0.00%
Tompkins Financial Corp300$1.00K0.00%
CWM, LLC164$1.00K0.00%

Sold out (24)

Institutions that held Veru Inc. at the end of Q4 2021 and filed for Q1 2022 without it.